(Total Views: 201)
Posted On: 10/18/2019 11:04:08 AM
Post# of 36551
From Tuesday Generex Conference Call - 15 October 2019 (Page 2/28)
See: https://www.generex.com/
"So, we've decided to rights to offering with NuGenerex Immuno-Oncology to Generex's shareholders. The right to offer would be offered to our shareholders a very appealing and beneficial rate, with the proceeds to be used for operations, clinical trials, and immediately comply with the NASDAQ listing " - CEO GENEREX
Got it right? Will NGIO be listed on Nasdaq? If true, that's great news!
Thanks Generex TEAM!
See: https://www.generex.com/
"So, we've decided to rights to offering with NuGenerex Immuno-Oncology to Generex's shareholders. The right to offer would be offered to our shareholders a very appealing and beneficial rate, with the proceeds to be used for operations, clinical trials, and immediately comply with the NASDAQ listing " - CEO GENEREX
Got it right? Will NGIO be listed on Nasdaq? If true, that's great news!
Thanks Generex TEAM!
(0)
(0)Scroll down for more posts ▼
